06-Oct-2021
Enterome to Attend Upcoming Conferences
Enterome to Attend Upcoming Conferences
Paris, France – October 4, 2021
ENTEROME SA, a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases, today announces that Pierre Belichard, CEO, will attend and take part in 1-on-1 meetings with institutional investors at the following conferences:
• BMO fall Life Sciences Private Company Showcase: October 14
• Jefferies Annual IBD Next Generation Therapeutics Summit: October 19
• Jefferies Global Healthcare Conference: November 16 -18
Editor Details
-
Company:
- PharmiWeb.com
-
Name:
- PW Editor
- Email:
-
Telephone:
- +441344851506
Last Updated: 06-Oct-2021
